Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer.

Journal

NEJM evidence
ISSN: 2766-5526
Titre abrégé: NEJM Evid
Pays: United States
ID NLM: 9918317485806676

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 6 2 2024
pubmed: 6 2 2024
entrez: 6 2 2024
Statut: ppublish

Résumé

Meta-Analysis of Surrogate End Points in Prostate CancerGharzai et al. report on the results of a meta-analysis, which concludes that unlike the case in localized prostate cancer, surrogate end points in advanced prostate cancer may not track overall survival.

Identifiants

DOI: 10.1056/EVIDoa2200195 PMID: 38320030
pubmed: 38320030
doi: 10.1056/EVIDoa2200195
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

EVIDoa2200195

Auteurs

Laila A Gharzai (LA)

Department of Radiation Oncology, Northwestern University, Chicago.

Ralph Jiang (R)

Department of Biostatistics, University of Michigan, Ann Arbor.

Elizabeth M Jaworski (EM)

Department of Radiation Oncology, University of Michigan, Ann Arbor.

Krystal Morales Rivera (K)

Department of Radiation Oncology, University of Michigan, Ann Arbor.

Robert T Dess (RT)

Department of Radiation Oncology, University of Michigan, Ann Arbor.

William C Jackson (WC)

Department of Radiation Oncology, University of Michigan, Ann Arbor.

Holly E Hartman (HE)

Department of Population and Quantitative Health Sciences, Case Western Reserve, Cleveland, OH.

Rohit Mehra (R)

Department of Pathology, University of Michigan, Ann Arbor.

Amar U Kishan (AU)

Department of Radiation Oncology, University of California, Los Angeles, Los Angeles.

Abhishek A Solanki (AA)

Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL.

Edward M Schaeffer (EM)

Department of Urology, Northwestern University, Chicago.

Felix Y Feng (FY)

Department of Radiation Oncology, University of California, San Francisco, San Francisco.

Nicholas G Zaorsky (NG)

Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve, Cleveland, OH.

Alejandro Berlin (A)

Department of Radiation Oncology, University of Toronto; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON.

Lee Ponsky (L)

Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve, Cleveland, OH.

Jonathan Shoag (J)

Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve, Cleveland, OH.

Yilun Sun (Y)

Department of Population and Quantitative Health Sciences, Case Western Reserve, Cleveland, OH.

Matthew J Schipper (MJ)

Department of Biostatistics, University of Michigan, Ann Arbor.
Department of Radiation Oncology, University of Michigan, Ann Arbor.

Jorge Garcia (J)

Department of Medicine, University Hospitals Seidman Cancer Center, Case Western Reserve, Cleveland, OH.

Daniel E Spratt (DE)

Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve, Cleveland, OH.

Classifications MeSH